Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
About Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
19
Pfizer
12
Amgen
4
Incyte Corporation
4
Merck Sharp & Dohme LLC
4
Allergan
3
Bayer
3
Boehringer Ingelheim
3
Helsinn Healthcare SA
3
Eli Lilly and Company
2
G1 Therapeutics, Inc.
2
Clinical Trials at Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
During the past decade, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 37 clinical trials were completed, i.e. on
average, 56.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 20 clinical trials were completed. i.e. 95.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
2005-12-27
2008-03-29
Completed
752
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2009-12-01
Completed
107
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting
2011-07-01
2012-11-01
Completed
743
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
2011-09-01
2016-05-01
Completed
640
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Pfizer" with 12 trials
sponsored, "Amgen" with 4 trials sponsored, "Incyte Corporation" with 4 trials sponsored and "Merck Sharp & Dohme LLC"
with 4 trials sponsored. Other sponsors include 39 different institutions and
companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet"
#1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
According to Clinical.Site data, the most researched conditions in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are
"Carcinoma, Non-Small-Cell Lung" (7 trials), "Breast Cancer" (6 trials), "Non-Small Cell Lung Cancer" (5 trials), "Gastric Cancer" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" in a lesser frequency.
Clinical Trials Intervention Types at Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
Most popular intervention types in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are "Drug" (82 trials), "Biological" (9 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (21 trials), "Carboplatin" (13 trials), "Gemcitabine" (13 trials), "Cisplatin" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
The vast majority of trials in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are
77 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
Currently, there are NaN active trials in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet".
undefined are not yet recruiting,
15 are recruiting,
18 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet,
undefined suspended trials,
and 13 terminated clinical trials to date.
Out of the total trials that were conducted in Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, 3 "Phase 1"
clinical trials were conducted, 22 "Phase 2" clinical
trials and 61 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".